CDK3
Basic information
Region (hg38): 17:76000855-76005999
Links
Phenotypes
GenCC
Source: 
ClinVar
This is a list of variants' phenotypes submitted to 
- not_specified (32 variants)
 
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDK3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001258.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 32 | 32 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 32 | 0 | 0 | 
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| CDK3 | protein_coding | protein_coding | ENST00000425876 | 7 | 5094 | 
| pLI Probability LOF Intolerant  | pRec Probability LOF Recessive  | Individuals with no LOFs  | Individuals with Homozygous LOFs  | Individuals with Heterozygous LOFs  | Defined | p | 
|---|---|---|---|---|---|---|
| 2.14e-7 | 0.468 | 125668 | 0 | 80 | 125748 | 0.000318 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.628 | 158 | 182 | 0.869 | 0.0000104 | 1972 | 
| Missense in Polyphen | 71 | 85.711 | 0.82837 | 918 | ||
| Synonymous | -1.27 | 91 | 76.8 | 1.18 | 0.00000441 | 622 | 
| Loss of Function | 0.810 | 12 | 15.4 | 0.778 | 8.95e-7 | 161 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.000235 | 0.000235 | 
| Ashkenazi Jewish | 0.00 | 0.00 | 
| East Asian | 0.000109 | 0.000109 | 
| Finnish | 0.00208 | 0.00208 | 
| European (Non-Finnish) | 0.000194 | 0.000167 | 
| Middle Eastern | 0.000109 | 0.000109 | 
| South Asian | 0.000229 | 0.000229 | 
| Other | 0.00 | 0.00 | 
dbNSFP
Source: 
- Function
 - FUNCTION: Serine/threonine-protein kinase that plays a critical role in the control of the eukaryotic cell cycle; involved in G0- G1 and G1-S cell cycle transitions. Interacts with CCNC/cyclin-C during interphase. Phosphorylates histone H1, ATF1, RB1 and CABLES1. ATF1 phosphorylation triggers ATF1 transactivation and transcriptional activities, and promotes cell proliferation and transformation. CDK3/cyclin-C mediated RB1 phosphorylation is required for G0-G1 transition. Promotes G1-S transition probably by contributing to the activation of E2F1, E2F2 and E2F3 in a RB1- independent manner. {ECO:0000269|PubMed:15084261, ECO:0000269|PubMed:18794154, ECO:0000269|PubMed:8846921}.;
 - Pathway
 - estrogen responsive protein efp controls cell cycle and breast tumors growth;IL-7 signaling;JAK STAT pathway and regulation;EPO signaling;VEGF 
(Consensus)  
Recessive Scores
- pRec
 - 0.208
 
Intolerance Scores
- loftool
 - 0.668
 - rvis_EVS
 - -0.16
 - rvis_percentile_EVS
 - 41.91
 
Haploinsufficiency Scores
- pHI
 - 0.968
 - hipred
 - N
 - hipred_score
 - 0.350
 - ghis
 - 0.532
 
Essentials
- essential_gene_CRISPR
 - N
 - essential_gene_CRISPR2
 - N
 - essential_gene_gene_trap
 - gene_indispensability_pred
 - E
 - gene_indispensability_score
 - 0.989
 
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | Medium | Medium | Medium | 
| Cancer | Medium | Medium | Medium | 
Mouse Genome Informatics
- Gene name
 - Cdk3-ps
 - Phenotype
 - normal phenotype;
 
Gene ontology
- Biological process
 - G1/S transition of mitotic cell cycle;protein phosphorylation;cellular response to DNA damage stimulus;cell population proliferation;G0 to G1 transition;cell division;regulation of cell cycle
 - Cellular component
 - nucleus
 - Molecular function
 - cyclin-dependent protein serine/threonine kinase activity;protein binding;ATP binding